4-85829-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_182524.4(ZNF595):c.325G>A(p.Glu109Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182524.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF595 | NM_182524.4 | c.325G>A | p.Glu109Lys | missense_variant | 4/4 | ENST00000610261.6 | NP_872330.1 | |
ZNF595 | NM_001286052.2 | c.229G>A | p.Glu77Lys | missense_variant | 3/3 | NP_001272981.1 | ||
ZNF595 | NM_001286053.2 | c.-225G>A | 5_prime_UTR_variant | 2/2 | NP_001272982.1 | |||
ZNF595 | NM_001286054.2 | c.-225G>A | 5_prime_UTR_variant | 5/5 | NP_001272983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF595 | ENST00000610261.6 | c.325G>A | p.Glu109Lys | missense_variant | 4/4 | 1 | NM_182524.4 | ENSP00000477392 | P1 | |
ZNF595 | ENST00000609518.5 | c.229G>A | p.Glu77Lys | missense_variant | 3/3 | 2 | ENSP00000476408 | |||
ZNF595 | ENST00000608255.2 | c.-225G>A | 5_prime_UTR_variant | 2/2 | 2 | ENSP00000476367 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.325G>A (p.E109K) alteration is located in exon 4 (coding exon 4) of the ZNF595 gene. This alteration results from a G to A substitution at nucleotide position 325, causing the glutamic acid (E) at amino acid position 109 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.